Health and Human Services Secretary Alex Azar today released a plan outlining two pathways the administration intends to explore to safely import certain drugs originally intended for foreign markets. The plan calls for HHS and the Food and Drug Administration to issue a proposed rule authorizing demonstration projects to import drugs from Canada safely at lower cost. States, wholesalers and pharmacists could submit demonstration proposals for review. It also calls for FDA to issue guidance for manufacturers seeking to import FDA-approved drug products that they sell in foreign countries to potentially offer them at a lower price than their current distribution contracts require.

Related News Articles

Headline
List prices for branded pharmaceutical products in the United States increased 159% between 2007 and 2018, an average of 9.1% per year, according to a study…
Headline
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’…
Headline
The Food and Drug Administration today approved the first generic albuterol sulfate inhaler to treat and prevent bronchospasms in patients with asthma or…
Headline
The Food and Drug Administration today released the first phase of its searchable Purple Book database, which includes all FDA-approved biosimilar and…
Headline
The House Ways and Means Health Subcommittee yesterday held a hearing on proposals to lower drug prices and promote new cures.  Witness Ge Bai, an…
Headline
The Campaign for Sustainable Rx Pricing today launched an ad campaign calling for Congress to pass bipartisan legislation to “hold Big Pharma accountable…